Michael S. Binkley

Radiation Oncology
965 High St
Palo Alto, CA 94301

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications

Navigating murky waters: risk scores for nodular lymphocyte-predominant Hodgkin lymphoma.

Navigating murky waters: risk scores for nodular lymphocyte-predominant Hodgkin lymphoma.

Journal: Haematologica
Published: August 03, 2026

Lattice Radiation Therapy as a Novel Approach for Renal Cell Carcinoma: A Case Series.

Lattice Radiation Therapy as a Novel Approach for Renal Cell Carcinoma: A Case Series.

Journal: Cureus
Published: April 15, 2026

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report.

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report.

Journal: Leukemia
Published: March 02, 2026

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Journal: Blood advances
Published: February 05, 2026

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Journal: Blood advances
Published: February 05, 2026

Treatment kinetics and local response during and after bridging radiotherapy prior to CAR-T cell therapy for lymphomas.

Treatment kinetics and local response during and after bridging radiotherapy prior to CAR-T cell therapy for lymphomas.

Journal: Leukemia & lymphoma
Published: December 26, 2025

Reduced-dose total skin electron beam radiotherapy in mycosis fungoides and Sézary syndrome: Systematic review and meta-analysis.

Reduced-dose total skin electron beam radiotherapy in mycosis fungoides and Sézary syndrome: Systematic review and meta-analysis.

Journal: International journal of radiation oncology, biology, physics
Published: December 02, 2025

Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032.

Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032.

Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025

Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis.

Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis.

Journal: Blood
Published: October 20, 2025

Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis.

Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis.

Journal: Blood
Published: October 20, 2025

Automated contouring, treatment planning, and quality assurance for total marrow lymphoid irradiation.

Automated contouring, treatment planning, and quality assurance for total marrow lymphoid irradiation.

Journal: Frontiers in oncology
Published: August 29, 2025

Risk Factors of Cardiotoxicity After Breast Cancer Radiation Therapy.

Risk Factors of Cardiotoxicity After Breast Cancer Radiation Therapy.

Journal: Advances in radiation oncology
Published: June 06, 2025
Showing 1-12 of 73

Last Updated: 09/26/2026